作者
Johan L.K. Van Hove,Marisa W. Friederich,Dana Strode,Roxanne A. Van Hove,Kristen Campbell,Rohit Sharma,Hardik Shah,Jane Estrella,Linda Gabel,Simon Horslen,Rohit Kohli,Mark A. Lovell,Alexander Miethke,Jean P. Molleston,René Romero,James E. Squires,Estella M. Alonso,Maria Oliva‐Hemker,Binita M. Kamath,Kathleen M. Loomes,Philip Rosenthal,Krupa R. Mysore,Laurel Cavallo,Pamela L. Valentino,John C. Magee,Shikha S. Sundaram,Ronald J. Sokol
摘要
Mitochondrial hepatopathies (MHs) are primary mitochondrial genetic disorders that can present as childhood liver disease. No recognized biomarkers discriminate MH from other childhood liver diseases. The protein biomarkers growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 (FGF21) differentiate mitochondrial myopathies from other myopathies. We evaluated these biomarkers to determine if they discriminate MH from other liver diseases in children.
午见千山
嗯哼
Billy
hzc
可爱的函函
坚强的广山
汉堡包
寻道图强
爆米花
spark810
YaGue
CipherSage
停摆的指针
热心市民小红花
Dr.Zhang
Yuxiao
stuffmatter
Nhiii
张三坟
yufanhui
皖公网安备34019202002308
